Navigation Links
Study raises questions about diagnosis, medical treatment of ADHD
Date:1/22/2008

ugh to differentiate between the two groups. Additional psychological testing is recommended to confirm the presence of cognitive impairments.

Researchers also found surprising results regarding the effectiveness of medicine in treating ADHD. In contrast to children in United States, youth in northern Finland are rarely treated with medicine for ADHD, yet the 'look' of the disorder its prevalence, symptoms, psychiatric comorbidity and cognition is relatively the same as in the U.S., where stimulant medication is widely used. The researchers point out that this raises important issues about the efficacy of the current treatments of ADHD in dealing with the disorder's long-term problems.

"We know medication is very effective in the short-term," said Smalley, who authored or co-authored each of the papers. "But the study raises important questions concerning the long-term efficacy of ADHD treatment. Here we have two different cultures and two different approaches to treatment, yet at the time of adolescence, there are few differences in the presentation and problems associated with ADHD."

Other findings from the wide-ranging study include:

  • Further confirmation that ADHD symptoms do change with age: Hyperactivity and impulsivity decrease with age, while inattention increasingly predominates. In fact, about two-thirds of children with ADHD continue to exhibit significant levels of inattentiveness and impairment into adolescence.

  • ADHD is associated with increased rates of other psychiatric problems. Most prominent in adolescence are depression; anxiety; oppositional behaviors, such as arguing, losing one's temper and being easily annoyed; and conduct disorders like vandalism and truancy. Surprisingly, post-traumatic stress disorder is significantly elevated among adolescents with ADHD, compared with non-ADHD youth. The prevalence of these co-occurring disorders is comparable to that found in
    '/>"/>

Contact: Mark Wheeler
mwheeler@mednet.ucla.edu
310-794-2265
University of California - Los Angeles
Source:Eurekalert

Page: 1 2 3

Related medicine news :

1. Another Study Links Western Diet to Heart, Health Risks
2. Nerites Receives NIH Grant to Study Novel Treatment for Preventing Dangerous Bacterial Infections on Urinary Stents and Catheters
3. New Kaiser Permanente study fortifies caffeines link to miscarriage
4. Kaiser Permanente study shows link between caffeine and miscarriage
5. Study looks at off-label use of biliary stents
6. Study: Brain connections strengthen during waking hours, weaken during sleep
7. National study will look at German-made heart pump for children needing heart transplants
8. Enlarged Prostate Treatment Study Shows Combination of AVODART(R) and Tamsulosin Provides Greater Benefit Than Either Medication Alone
9. Study finds significant differences in protocols hospitals use to determine brain death
10. Bankers Life and Casualty Company Joins LifePlans, Inc. and the Department of Health and Human Services to Launch Fall Prevention Program Study For Americas Seniors
11. Latest Study Says Statins Dont Slow Alzheimers

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/4/2009)...Ariz., Dec. 4 Healthcare Trust of ... real estate investment trust, announced the execu... three building medical office portfolio located i...yne, Indiana for approximately $20,500,000. The c...action of a number of conditions. ,, The approx...
(Date:12/4/2009)... Dec. 4 In response to ...y,s (DEA) classification of boldione, desoxymethyl...e as "anabolic steroids", under the Controlled Sub...d CEO of the Natural Products Association (NPA), t...ing retailers and manufacturers of dietary supplem...
(Date:12/4/2009)... Americans are recruited annually to participate i...man Research Protection (AHRP), and most will be c...ch institutions view payments to volunteers as com...on for potential risks related to participating in...nteers have a very different view of clinical tria...
(Date:12/4/2009)...ure from federal regulators to crack down on abuse...4 (HealthDay News) -- The makers of 24 different p...l regulators with plans to curb the abuse of these...have been under pressure from U.S. Food and Drug A...hundreds of fatal overdoses that occur with these ...
(Date:12/4/2009)...-lowering drugs known as statins are among the mos... by researchers at Fred Hutchinson Cancer Research...ll transplant patients from one of the most seriou... graft-versus-host disease, or GVHD. The findings ...urnal Blood . , In a retrospective study of 567 ...
Breaking Medicine News(10 mins):Health News:Healthcare Trust of America, Inc. Executes Agreement to Acquire a 92,500 Square Foot Medical Office Portfolio Located in Texas and Indiana 2Health News:Natural Products Association Issues Statement on DEA's Steroid Classification Action 2Health News:Human guinea pigs wary of high-paying medical trials 2Health News:Makers of Powerful Painkillers Present Safety Plans 2Health News:Cholesterol-lowering drugs also may protect stem cell transplant patients from GVHD 2
...rastic reduction in chicken prices and public awar...ken back into the Indian menu//. A large number of...chicken, despite heath officials stating that well...he farmers, especially those with small holdings, ...
...AIDS awareness program, scheduled to take place in...es and plays//. The awareness programme would be t...tibility of the disease, particularly among young ...p of music bands like Euphoria and a band from Miz...
...ke University Medical Center have found that takin...ry artery disease increases the chances of dying./...risk of dying for patients who took such medicatio...ideration. "This finding that antidepressant u...
...ion system for junior doctor posts is not in the i...job prospects of many top students. This was the o... The system being followed is the “Modernisin...med by specialists is that the process is untested...
...ted on Remicade (infliximab) showed rapid, signifi...re plaque psoriasis. The stud mainly used placebo-...kg. The continuous eight week maintenance therapy ... patients treated with Remicade 3 mg/kg and 75 % o...
...' warn consumers on how to spot the misleading pro...y and nutritional HGH products.// Various sp...product manufacturers, distributors, or resellers ....net), representing 17,500 physicians in 86 nation...
Other Medicine News:Health News:Poultry Industry In India Suffers A Set Back 2Health News:Music Helps in Spreading AIDS Awareness 2Health News:Online recruitment criticised by doctors 2Health News:Beware Of Bogus Claims by HGH Spray Internet Marketers 2Health News:Beware Of Bogus Claims by HGH Spray Internet Marketers 3
(Date:12/4/2009)... CITY, Dec. 4 Dynatronic...gned a sole-source vendor agreement to provide the...sical Therapy with 65 clinics located in Tennessee...he sole-source supplier to Benchmark Physical Ther...dent of sales and marketing at Dynatronics. "Bench...
(Date:12/4/2009)..., WASHINGTON, Dec. 4 ...rt published by the Pharmaceutical Research and ...s 97 new drugs and vaccines in development for HIV... found that the 97 products in development includ...ither in human clinical trials or awaiting approva...
(Date:12/4/2009)... Md., Dec. 4 PharmAthene...veloping medical countermeasures against biologica...ompany is presenting results of a study demonstrat...lation anthrax model in the New Zealand White (NZW...oral session at the HHS Public Health Emergency Me...
Breaking Medicine Technology:U.S. Pharmaceutical Companies Developing 97 New Drugs and Vaccines to Fight HIV/AIDS 2PharmAthene Presents Animal Model Data for Valortim(R) at the 2009 BARDA Industry Conference / PHEMCE Stakeholders Workshop 2PharmAthene Presents Animal Model Data for Valortim(R) at the 2009 BARDA Industry Conference / PHEMCE Stakeholders Workshop 3PharmAthene Presents Animal Model Data for Valortim(R) at the 2009 BARDA Industry Conference / PHEMCE Stakeholders Workshop 4PharmAthene Presents Animal Model Data for Valortim(R) at the 2009 BARDA Industry Conference / PHEMCE Stakeholders Workshop 5PharmAthene Presents Animal Model Data for Valortim(R) at the 2009 BARDA Industry Conference / PHEMCE Stakeholders Workshop 6New material for nanoscale computer chips 13620 1New material for nanoscale computer chips 13620 2Alternative Therapies And Their Growing Popularity 54813 1Alternative Therapies And Their Growing Popularity 54813 2Alternative Therapies And Their Growing Popularity 54813 3Alternative Therapies And Their Growing Popularity 54813 4Induced Labor May Prevent Need for Cesarean Section 54811 1Induced Labor May Prevent Need for Cesarean Section 54811 2
...d that the U.S. Food and Drug Administration (FDA)... for the Biologics License Application (BLA) for A...IL-6) receptor-inhibiting monoclonal antibody stud...ately to severely active rheumatoid arthritis (RA)... Evaluation and Mitigation Strategy (REMS) require...
...amp; Lymphoma Society (LLS) and Memgen, LLC jointl...f ISF35, a cancer vaccine, at the University of C...llaborating on this trial in the hopes that it wil...proach aimed at treating patients with fludarabine... leukemia (CLL). , , Doctors at UCSD have al...
Other Medicine Technology:Roche and FDA Agree on Pathway Towards U.S. Approval of ACTEMRA(R) (tocilizumab) 2Roche and FDA Agree on Pathway Towards U.S. Approval of ACTEMRA(R) (tocilizumab) 3Roche and FDA Agree on Pathway Towards U.S. Approval of ACTEMRA(R) (tocilizumab) 4Roche and FDA Agree on Pathway Towards U.S. Approval of ACTEMRA(R) (tocilizumab) 5The Leukemia & Lymphoma Society and Memgen Announce New Chronic Lymphocytic Leukemia Clinical Trial 2The Leukemia & Lymphoma Society and Memgen Announce New Chronic Lymphocytic Leukemia Clinical Trial 3
Sugita Aneurysm Clip Straight (L)
BacT/Alert 3D Signature
Vitek 2 - XL
IDS Rapid STR
Medicine Products: